GSK
GSK boosts stake in Aspen
May 12, 2009Sales and Marketing GSK, generics
GlaxoSmithKline has extended its stake in the South African generics company Aspen to a 16% shareholding. In return it will …
GSK claims superiority for Cervarix in head-to-head trial
May 11, 2009Research and Development, Sales and Marketing GSK, vaccines
GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …
GSK pledges help in flu outbreak
April 28, 2009Research and Development GSK, h1n1
GlaxoSmithKline has pledged to closely monitor the swine flu outbreak that began in Mexico, and assist in access to treatment …
GSK and Pfizer joint venture more than a defensive move
April 27, 2009Research and Development, Sales and Marketing GSK, Pfizer
GSK and Pfizer have agreed to merge their respective HIV businesses, creating a single specialist entity with total pro-forma sales …
GSK freezes prices in Germany as part of PR trail
April 24, 2009Sales and Marketing GSK, Germany
GlaxoSmithKline has announced a price freeze on its drugs and vaccines in Germany for 2009. The freeze applies to drugs …
GSK launches Alli in Europe
April 22, 2009Sales and Marketing Alli, Europe, GSK
GSK has launched Alli, making it the first clinically proven over-the-counter weight loss aid to be available in pharmacies across …
GSK buys Stiefel for $3.6bn
April 20, 2009Research and Development, Sales and Marketing GSK, MA
GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …
GSK and Pfizer to create HIV joint venture company
April 16, 2009Research and Development, Sales and Marketing GSK, HIV, Pfizer
The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …
Working Life: Maneesh Juneja
April 3, 2009Research and Development GSK, productivity
How did you find your way into your current role? After graduating with a degree in business & computing, I …
GSK pledges further trial transparency
March 26, 2009Research and Development, Sales and Marketing GSK
GlaxoSmithKline is to make its clinical trials more transparent through a series of moves it believes will facilitate clinical research. …
GSK linked to Allergan takeover
March 26, 2009Sales and Marketing Allergan, GSK
GlaxoSmithKline may be considering a bid to buy Allergan, the company behind 'cosmaceutical' products such as Botox. Analysts have seized …
GlaxoSmithKline and UCL to develop biologic
March 24, 2009Research and Development GSK
Researchers at University College London are to work with GlaxoSmithKline to develop a new treatment for the rare and often …
Cervarix adverse reactions as expected, says MHRA
March 11, 2009Sales and Marketing GSK, vaccines
The government has played down reports about adverse reactions to GlaxoSmithKline's Cervarix, saying they are in line with expectations. The …
GSK’s diabetes candidate enters phase III
February 19, 2009Research and Development GSK, diabetes
A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …
GSK: renewing the HIV pipeline
February 16, 2009Research and Development GSK, HIV
GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
